These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2905)

  • 1. Formation and in-vivo-distribution of different 99mTc-Sn-pyrophosphate complexes.
    Schümichen C; Roth KH; Hoffmann G
    Nucl Med (Stuttg); 1975 Dec; 14(4):323-9. PubMed ID: 2905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
    Schümichen C; Hohloch M; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. I. In vivo studies.
    Schümichen C; Walden J; Hoffmann G
    Nuklearmedizin; 1977 Jul; 16(3):100-3. PubMed ID: 197498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. II. In vitro studies.
    Schümichen C; Mackenbrock B; Hoffmann G
    Nuklearmedizin; 1977 Aug; 16(4):157-62. PubMed ID: 198752
    [No Abstract]   [Full Text] [Related]  

  • 5. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.
    Schümichen C; Hohloch H; Schiller A; Pohle W; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):98-104. PubMed ID: 38438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
    McRae J; Hambright P; Valk P; Bearden AJ
    J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the bone seeking properties of short-chained 99mTc-Sn-polyphosphates.
    Schümichen C; Nakken KF
    Nucl Med (Stuttg); 1974 Aug; 13(2):139-43. PubMed ID: 4373697
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
    Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
    Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
    Atamaniuk NP; Mechev DS
    Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
    J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concentration of 99mTc-tin-phosphate complexes in soft tissues].
    Büll U; von Lieven H; Leisner B
    Nucl Med (Stuttg); 1975 Jun; 14(2):91-105. PubMed ID: 170592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the parameters related to the formation of 99mTc-pyrophosphate complexes using gel chromatography column scanning.
    Shafiq YF; Al-Janabi MA; Al-Azzawi HM; Abdel-Azeez MA; Al-Hissoni MH; Jassim MN
    Nuklearmedizin; 1985 Jun; 24(3):146-9. PubMed ID: 2997754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m-pyrophosphate: studies in vivo and in vitro.
    Kaye M; Silverton S; Rosenthall L
    J Nucl Med; 1975 Jan; 16(1):40-5. PubMed ID: 162947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-Sn-pyrophosphate complexes, an investigation of its possible structures.
    Schümichen C; Rörvik-Schümichen K; Hoffmann G
    Nucl Med (Stuttg); 1974 Nov; 13(3):253-7. PubMed ID: 4375276
    [No Abstract]   [Full Text] [Related]  

  • 16. Technetium-99m-Sn-pyrophosphate pharmaco-kinetics and bone image changes in parathyroid disease.
    Krishnamurthy GT; Brickman AS; Blahd WH
    J Nucl Med; 1977 Mar; 18(3):236-42. PubMed ID: 190364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2012 Aug; 39(6):763-9. PubMed ID: 22459337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone kinetics of calcium-45 and pyrophosphate labeled with technetium-96: an autoradiographic evaluation.
    Guillemart A; Le Pape A; Galy G; Besnard JC
    J Nucl Med; 1980 May; 21(5):466-70. PubMed ID: 6246225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of acute myocardial infarcts in dogs with 99mTc-stannous pyrophosphate scintigrams.
    Stokely EM; Buja LM; Lewis SE; Parkey RW; Bonte FJ; Harris RA; Willerson JT
    J Nucl Med; 1976 Jan; 17(1):1-5. PubMed ID: 172612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal uptake of pyrophosphate labeled with technetium-95m and technetium-96, as evaluated by autoradiography.
    Guillemart A; Besnard JC; Le Pape A; Galy G; Fetissoff F
    J Nucl Med; 1978 Aug; 19(8):895-9. PubMed ID: 210266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.